Literature DB >> 30758381

Zinc ion coordination significantly improved the transfection efficiency of low molecular weight polyethylenimine.

Huapan Fang1, Lin Lin, Jie Chen, Jiayan Wu, Huayu Tian, Xuesi Chen.   

Abstract

Polycationic gene carriers are attracting increasing attention for their use as gene delivery systems. Herein, a novel and high-performance polycationic gene carrier (i.e., Zn-DPPA2) was constructed by introducing a dipicolylamine compound along with zinc ion coordination onto polyethylenimine (PEI1.8k) via Schiff base bonds. Zn-DPPA2 exhibited efficient transfection and negligible cytotoxicity. Zn-DPPA2/DNA complexes possessed significant endocytosis efficiency and excellent endosomal escape ability. Additionally, this polycaitionic gene carrier showed an excellent ability as an antiserum. The nanoscale size and good size stability ensured that Zn-DPPA2/DNA could accumulate in tumor tissue through the enhanced permeability and retention (EPR) effect. Moreover, Zn-DPPA2/DNA complexes exhibited efficient transfection in tumor tissue after intravenous injection. This strategy provided a new idea for polycationic gene carrier construction, which has prospects for widespread application in the field of gene therapy.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30758381     DOI: 10.1039/c9bm00039a

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  3 in total

1.  Combination of epigenetic regulation with gene therapy-mediated immune checkpoint blockade induces anti-tumour effects and immune response in vivo.

Authors:  Huapan Fang; Zhaopei Guo; Jie Chen; Lin Lin; Yingying Hu; Yanhui Li; Huayu Tian; Xuesi Chen
Journal:  Nat Commun       Date:  2021-11-18       Impact factor: 14.919

Review 2.  Applications and challenges of biomaterial mediated mRNA delivery.

Authors:  Huapan Fang; Qian Chen
Journal:  Explor Target Antitumor Ther       Date:  2022-08-31

3.  CD47KO/CRT dual-bioengineered cell membrane-coated nanovaccine combined with anti-PD-L1 antibody for boosting tumor immunotherapy.

Authors:  Shengyang Liu; Jiayan Wu; Yuanji Feng; Xiaoya Guo; Tong Li; Meng Meng; Jie Chen; Daquan Chen; Huayu Tian
Journal:  Bioact Mater       Date:  2022-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.